The prostate cancer cell models obtained, namely C4-2/LOX-1(+) [clone 5], C4-2/LOX-1(−) [clone shRNA-B1] and native C4-2 cell line, were used as models in all assays performed in this work. This evidence concerns the gene OLR1 and prostate carcinoma.